Debjit Chattopadhyay
Stock Analyst at Guggenheim
(3.37)
# 1,046
Out of 4,413 analysts
47
Total ratings
50%
Success rate
2.57%
Average return
Main Sectors:
Top Industries:
26 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $445 → $450 | $396.20 | +13.58% | 4 | Apr 18, 2024 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $22 | $7.77 | +183.14% | 1 | Mar 26, 2024 | |
| DYN Dyne Therapeutics | Maintains: Buy | $33 → $37 | $25.46 | +45.33% | 2 | Mar 7, 2024 | |
| PRME Prime Medicine | Maintains: Buy | $24 → $20 | $4.86 | +311.52% | 2 | Mar 5, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $130 → $175 | $157.99 | +10.77% | 3 | Feb 27, 2024 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $30 | $21.66 | +38.50% | 1 | Jan 18, 2024 | |
| SLNO Soleno Therapeutics | Assumes: Buy | $40 | $45.53 | -12.15% | 1 | Nov 21, 2023 | |
| BMRN BioMarin Pharmaceutical | Reiterates: Buy | $110 | $82.13 | +33.93% | 3 | Sep 13, 2023 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $9 → $10 | $9.29 | +7.64% | 2 | Aug 15, 2023 | |
| QURE uniQure | Reiterates: Buy | $53 | $4.39 | +1,107.29% | 3 | Feb 28, 2023 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $43 → $29 | $2.84 | +921.13% | 1 | Nov 21, 2022 | |
| PASG Passage Bio | Maintains: Buy | $13 → $11 | $1.30 | +746.15% | 2 | Nov 11, 2022 | |
| RARE Ultragenyx Pharmaceutical | Upgrades: Buy | $50 | $44.02 | +13.58% | 2 | Oct 13, 2022 | |
| ALNY Alnylam Pharmaceuticals | Downgrades: Neutral | n/a | $147.36 | - | 1 | Jun 27, 2022 | |
| IONS Ionis Pharmaceuticals | Initiates: Buy | $64 | $41.99 | +52.42% | 1 | Mar 1, 2022 | |
| BEAM Beam Therapeutics | Initiates: Buy | $130 | $22.05 | +489.57% | 1 | Jan 5, 2022 | |
| TSHA Taysha Gene Therapies | Initiates: Buy | n/a | $2.45 | - | 1 | Dec 16, 2021 | |
| NTLA Intellia Therapeutics | Initiates: Buy | n/a | $21.98 | - | 1 | Oct 5, 2021 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | n/a | $128.80 | - | 4 | Aug 31, 2020 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $28.65 | - | 3 | Aug 24, 2020 | |
| AVRO AVROBIO | Downgrades: Neutral | n/a | $1.19 | - | 2 | Mar 31, 2020 | |
| DTIL Precision BioSciences | Maintains: Buy | $630 → $570 | $9.84 | +5,692.68% | 1 | Mar 11, 2020 | |
| ZYME Zymeworks | Reiterates: Buy | n/a | $8.33 | - | 1 | Mar 3, 2020 | |
| WVE Wave Life Sciences | Maintains: Buy | n/a | $4.85 | - | 1 | Jan 2, 2020 | |
| BOLD Boundless Bio | Maintains: Buy | n/a | $11.46 | - | 1 | Oct 12, 2018 | |
| AGIO Agios Pharmaceuticals | Downgrades: Neutral | n/a | $32.76 | - | 2 | Jun 26, 2017 |
Vertex Pharmaceuticals
Apr 18, 2024
Maintains: Buy
Price Target: $445 → $450
Current: $396.20
Upside: +13.58%
Voyager Therapeutics
Mar 26, 2024
Initiates: Buy
Price Target: $22
Current: $7.77
Upside: +183.14%
Dyne Therapeutics
Mar 7, 2024
Maintains: Buy
Price Target: $33 → $37
Current: $25.46
Upside: +45.33%
Prime Medicine
Mar 5, 2024
Maintains: Buy
Price Target: $24 → $20
Current: $4.86
Upside: +311.52%
Krystal Biotech
Feb 27, 2024
Maintains: Buy
Price Target: $130 → $175
Current: $157.99
Upside: +10.77%
NewAmsterdam Pharma Company
Jan 18, 2024
Initiates: Buy
Price Target: $30
Current: $21.66
Upside: +38.50%
Soleno Therapeutics
Nov 21, 2023
Assumes: Buy
Price Target: $40
Current: $45.53
Upside: -12.15%
BioMarin Pharmaceutical
Sep 13, 2023
Reiterates: Buy
Price Target: $110
Current: $82.13
Upside: +33.93%
Centessa Pharmaceuticals
Aug 15, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $9.29
Upside: +7.64%
uniQure
Feb 28, 2023
Reiterates: Buy
Price Target: $53
Current: $4.39
Upside: +1,107.29%
Allogene Therapeutics
Nov 21, 2022
Maintains: Buy
Price Target: $43 → $29
Current: $2.84
Upside: +921.13%
Passage Bio
Nov 11, 2022
Maintains: Buy
Price Target: $13 → $11
Current: $1.30
Upside: +746.15%
Ultragenyx Pharmaceutical
Oct 13, 2022
Upgrades: Buy
Price Target: $50
Current: $44.02
Upside: +13.58%
Alnylam Pharmaceuticals
Jun 27, 2022
Downgrades: Neutral
Price Target: n/a
Current: $147.36
Upside: -
Ionis Pharmaceuticals
Mar 1, 2022
Initiates: Buy
Price Target: $64
Current: $41.99
Upside: +52.42%
Beam Therapeutics
Jan 5, 2022
Initiates: Buy
Price Target: $130
Current: $22.05
Upside: +489.57%
Taysha Gene Therapies
Dec 16, 2021
Initiates: Buy
Price Target: n/a
Current: $2.45
Upside: -
Intellia Therapeutics
Oct 5, 2021
Initiates: Buy
Price Target: n/a
Current: $21.98
Upside: -
Sarepta Therapeutics
Aug 31, 2020
Maintains: Buy
Price Target: n/a
Current: $128.80
Upside: -
Galapagos NV
Aug 24, 2020
Downgrades: Neutral
Price Target: n/a
Current: $28.65
Upside: -
AVROBIO
Mar 31, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
Precision BioSciences
Mar 11, 2020
Maintains: Buy
Price Target: $630 → $570
Current: $9.84
Upside: +5,692.68%
Zymeworks
Mar 3, 2020
Reiterates: Buy
Price Target: n/a
Current: $8.33
Upside: -
Wave Life Sciences
Jan 2, 2020
Maintains: Buy
Price Target: n/a
Current: $4.85
Upside: -
Boundless Bio
Oct 12, 2018
Maintains: Buy
Price Target: n/a
Current: $11.46
Upside: -
Agios Pharmaceuticals
Jun 26, 2017
Downgrades: Neutral
Price Target: n/a
Current: $32.76
Upside: -